Saint Louis University;Fred Hutchinson Cancer Research Center
发明人:
Francis M. SVERDRUP,Stephen J. TAPSCOTT,Jonathan OLIVA,Amy E. CAMPBELL,Marvin J. MEYERS
申请号：
US16766030
公开号：
US20200297696A1
申请日:
2018.11.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides methods of treating a patient comprising administering a p38 inhibitor for the treatment of FSHD. In some embodiments, the present methods comprise using one or more p38 inhibitors as a therapeutic agent for the treatment of FSHD patients including patients who are being treated with one or more palliative treatments such as therapy and/or agents which lead to increased muscle mass.
